Latest Expert Opinions

Signal
Opinion
Expert
COMMENT
COMMENT
June 24, 2019
A defensive stock in an RRSP during a downturn or if interest rates decline? He hasn't looked at this in a long time. The demand for planes in 20 years will be huge due to demand in emerging markets. We will need pilots. CAE has had an amazing run, so the valuation is high. He needs to research this more to have an opinion.
CAE Inc (CAE-T)
June 24, 2019
A defensive stock in an RRSP during a downturn or if interest rates decline? He hasn't looked at this in a long time. The demand for planes in 20 years will be huge due to demand in emerging markets. We will need pilots. CAE has had an amazing run, so the valuation is high. He needs to research this more to have an opinion.
Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$34.660
Owned
No
BUY
BUY
June 24, 2019

He likes the airlines and expects the US economy to expand. The number of US airlines have shrunk a lot, down to four, but they are mispriced to their relationship to loyalty-point cards. Delta signed a deal with AmEx where Delta believes they will have $7 billion in excess cash flow by 2023. That's pretty good. Everybody loves loyalty points to buy seats. It benefit consumers and airlines which have done a great job of upselling. Fuel prices have been a concern, but the oil price has remained low. Even if the economy heads into recession, Delta's balance sheet is lean and mean.

He likes the airlines and expects the US economy to expand. The number of US airlines have shrunk a lot, down to four, but they are mispriced to their relationship to loyalty-point cards. Delta signed a deal with AmEx where Delta believes they will have $7 billion in excess cash flow by 2023. That's pretty good. Everybody loves loyalty points to buy seats. It benefit consumers and airlines which have done a great job of upselling. Fuel prices have been a concern, but the oil price has remained low. Even if the economy heads into recession, Delta's balance sheet is lean and mean.

Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$56.070
Owned
Yes
DON'T BUY
DON'T BUY
June 24, 2019

A great performer, though it stalled in late-2018 due to weak guidance. The debt level prevents him from researching this name more. They've made lots of acqusitions in the past, but maybe that's caught up with them. Either CPP or the teachers' union has made a purchase of them recently, which has benefited PBH. Debt is a worry.

A great performer, though it stalled in late-2018 due to weak guidance. The debt level prevents him from researching this name more. They've made lots of acqusitions in the past, but maybe that's caught up with them. Either CPP or the teachers' union has made a purchase of them recently, which has benefited PBH. Debt is a worry.

Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$87.800
Owned
No
TOP PICK
TOP PICK
June 24, 2019
A few years ago, the new CEO transformed this from a listings business to a data analystics business and gaining more revenues outside Canada. Now, 50% of their business is data analystics, selling information to companies like BNN. TMX benefits now from cannabis and cryptos. It's trading at a big discount to other exchanges, so there's a lot of upside. (Analysts’ price target is $102.67)
TMX Group (X-T)
June 24, 2019
A few years ago, the new CEO transformed this from a listings business to a data analystics business and gaining more revenues outside Canada. Now, 50% of their business is data analystics, selling information to companies like BNN. TMX benefits now from cannabis and cryptos. It's trading at a big discount to other exchanges, so there's a lot of upside. (Analysts’ price target is $102.67)
Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$91.740
Owned
Yes
TOP PICK
TOP PICK
June 24, 2019
Just because the population is aging, doesn't mean you'll benefit from it. BDX is in medical supplies, not drugs, supplying hospitals. They've pulled back a little, because a product is under FDA review. They have a good record of raising their dividend, and they have a long runway of opportunities ahead. (Analysts’ price target is $259.67)
Just because the population is aging, doesn't mean you'll benefit from it. BDX is in medical supplies, not drugs, supplying hospitals. They've pulled back a little, because a product is under FDA review. They have a good record of raising their dividend, and they have a long runway of opportunities ahead. (Analysts’ price target is $259.67)
Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$249.980
Owned
Yes
TOP PICK
TOP PICK
June 24, 2019
They buy other software companies, around 200 now and could acquire many more. Managers own a lot of stock, and that's a great sign. They know what they're doing. (Analysts’ price target is $1223.33)
They buy other software companies, around 200 now and could acquire many more. Managers own a lot of stock, and that's a great sign. They know what they're doing. (Analysts’ price target is $1223.33)
Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$1223.930
Owned
Yes